PRICE T ROWE ASSOCIATES INC /MD/

Position in RAPP — Rapport Therapeutics, Inc.

CIK 80255 BALTIMORE, MD

Position in RAPP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$32,812,874

+$5,701,467 QoQ

Shares Held

787,446

-9.1% QoQ

Ownership

1.64%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 159 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. RAPP ranks #80 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	TWST	Twist Bioscience Corp	3,634,652	$373,932,997

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,812,874	787,446	-9.1%	Shares	Sole	2026-08-14
2026-03-31	$27,111,407	866,456	-1.7%	Shares	Defined	2026-05-15
2025-12-31	$26,748,016	881,609	-20.0%	Shares	Sole	2026-02-17
2025-09-30	$32,741,012	1,102,391	-27.7%	Shares	Sole	2025-11-14
2025-06-30	$17,345,150	1,525,519	+42.1%	Shares	Sole	2025-08-14
2025-03-31	$10,764,275	1,073,208	-6.1%	Shares	Sole	2025-05-14
2024-12-31	$20,283,631	1,143,384	+9.2%	Shares	Sole	2025-02-14
2024-09-30	$21,450,915	1,047,408	-23.0%	Shares	Sole	2024-11-14
2024-06-30	$31,647,672	1,360,605	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.